WATSON 3449 20 mg (Morphine sulfate extended release 20 mg)

Pill imprint WATSON 3449 20 mg has been identified as Morphine sulfate extended release 20 mg.

Morphine is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Morphine sulfate extended release

Imprint:

WATSON 3449 20 mg

Strength:

20 mg

Color:

Yellow & White

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Narcotic analgesics

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

2 - High potential for abuse

Manufacturer:

Watson Laboratories, Inc.

National Drug Code (NDC):

00591-3449

Inactive Ingredients:

corn starch
diethyl phthalate
ethylcelluloses
polyethylene glycol 6000
sucrose
povidone k30
magnesium silicate
ferric oxide black
gelatin
propylene glycol
titanium dioxide
D&C Yellow No. 10
hypromellose 2910 (5 mPa.s)
methacrylic acid - ethyl acrylate copolymer (1:1) type a

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.